市場調查報告書

注射型藥物輸送的全球市場

Injectable Drugs Delivery

出版商 Global Industry Analysts, Inc. 商品編碼 893749
出版日期 內容資訊 英文 138 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
注射型藥物輸送的全球市場 Injectable Drugs Delivery
出版日期: 2019年07月01日內容資訊: 英文 138 Pages
簡介

這份報告提供全球注射型藥物輸送市場相關調查分析,彙整市場概要,市場趨勢,今後預測等相關考察,美國,加拿大,日本,歐洲,亞太地區,全球其他各國的各市場相關分析,主要企業的簡介等相關資訊。

第1章 調查方法

第2章 摘要整理

  • 市場概要
    • 全球企業市場佔有率
    • 全球注射型藥物輸送市場佔有率方案
    • 全球企業市場佔有率:各市場區隔
    • 設備(市場區隔)
    • 劑型(市場區隔)
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 歐洲的其他各國
  • 亞太地區
  • 全球其他各國

第4章 競爭

  • BAXTER INTERNATIONAL
  • ELCAM MEDICAL
  • ELI LILLY AND COMPANY
  • GERRESHEIMER AG
  • INJEX PHARMA GMBH
  • NOVARTIS INTERNATIONAL AG
  • NOVO NORDISK A/S
  • SCHOTT AG
  • TERUMO CORPORATION
  • TEVA PHARMACEUTICALS USA
  • WEST PHARMACEUTICAL SERVICES

第5章 彙整

目錄
Product Code: MCP12728

Injectable Drugs Delivery market worldwide is projected to grow by US$446.4 Billion, guided by a compounded growth of 11.4%. Staying on top of trends is essential for decision makers to leverage this emerging opportunity. The report addresses this very need and provides the latest scoop on all major market segments. Device, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$158.1 Billion by the year 2025, Device will bring in healthy gains adding significant momentum to global growth.

While global megatrends sweeping through the market influence the primary direction of growth, regional markets are swayed by more granular locally unique business drivers. Representing the developed world, the United States will maintain a 14% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$34.7 Billion to the region's size and clout in the next 5 to 6 years. Over US$40.1 Billion worth of projected demand in the region will come from other emerging Eastern European markets. In Japan, Device will reach a market size of US$11.3 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 10.8% over the next couple of years and add approximately US$74.8 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Baxter International, Inc. (USA); Becton, Dickinson and Company (USA); Elcam Medical (Israel); Eli Lilly and Company (USA); Gerresheimer AG (Germany); INJEX Pharma GmbH (Germany); Novartis International AG (Switzerland); Novo Nordisk A/S (Denmark); SCHOTT AG (Germany); Terumo Corporation (Japan); Teva Pharmaceuticals USA, Inc. (USA); West Pharmaceutical Services, Inc. (USA)

Table of Contents

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Injectable Drugs Delivery Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Global Competitor Market Shares by Segment
  • Device (Segment) Global Competitor Market Share Positioning for 2019 & 2025
  • Formulation (Segment) Market Share Breakdown of Key Players: 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Injectable Drugs Delivery Global Market Estimates and Forecasts in $ Million by Region/Country: 2018-2025
  • TABLE 2: Injectable Drugs Delivery Global Retrospective Market Scenario in $ Million by Region/Country: 2009-2017
  • TABLE 3: Injectable Drugs Delivery Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Formulation (Segment) Potential Growth Markets Worldwide in $ Million: 2018 to 2025
  • TABLE 5: Formulation (Segment) Historic Market Perspective by Region/Country in $ Million: 2009 to 2017
  • TABLE 6: Formulation (Segment) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 7: Device (Segment) World Market by Region/Country in $ Million: 2018 to 2025
  • TABLE 8: Device (Segment) Historic Market Analysis by Region/Country in $ Million: 2009 to 2017
  • TABLE 9: Device (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 10: Other End-Uses (End-Use) Sales Estimates and Forecasts in $ Million by Region/Country for the Years 2018 through 2025
  • TABLE 11: Other End-Uses (End-Use) Analysis of Historic Sales in $ Million by Region/Country for the Years 2009 to 2017
  • TABLE 12: Other End-Uses (End-Use) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025
  • TABLE 13: Home Care (End-Use) Demand Potential Worldwide in $ Million by Region/Country: 2018-2025
  • TABLE 14: Home Care (End-Use) Historic Sales Analysis in $ Million by Region/Country: 2009-2017
  • TABLE 15: Home Care (End-Use) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Hospitals & Clinics (End-Use) Global Market Estimates & Forecasts in $ Million by Region/Country: 2018-2025
  • TABLE 17: Hospitals & Clinics (End-Use) Retrospective Demand Analysis in $ Million by Region/Country: 2009-2017
  • TABLE 18: Hospitals & Clinics (End-Use) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Research Laboratories (End-Use) Worldwide Latent Demand Forecasts in $ Million by Region/Country: 2018-2025
  • TABLE 20: Research Laboratories (End-Use) Global Historic Analysis in $ Million by Region/Country: 2009-2017
  • TABLE 21: Research Laboratories (End-Use) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Injectable Drugs Delivery Market Share (in %) by Company: 2019 & 2025
    • Device (Segment) Market Share Analysis (in %) of Leading Players in the US for 2019 & 2025
    • Formulation (Segment) Competitor Revenue Share (in %) in the US: 2019 & 2025
    • TABLE 22: United States Injectable Drugs Delivery Market Estimates and Projections in $ Million by Segment: 2018 to 2025
    • TABLE 23: Injectable Drugs Delivery Market in the United States by Segment: A Historic Review in $ Million for 2009-2017
    • TABLE 24: United States Injectable Drugs Delivery Market Share Breakdown by Segment: 2009 VS 2019 VS 2025
    • TABLE 25: United States Injectable Drugs Delivery Latent Demand Forecasts in $ Million by End-Use: 2018 to 2025
    • TABLE 26: Injectable Drugs Delivery Historic Demand Patterns in the United States by End-Use in $ Million for 2009-2017
    • TABLE 27: Injectable Drugs Delivery Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 28: Canadian Injectable Drugs Delivery Market Estimates and Forecasts in $ Million by Segment: 2018 to 2025
    • TABLE 29: Canadian Injectable Drugs Delivery Historic Market Review by Segment in $ Million: 2009-2017
    • TABLE 30: Injectable Drugs Delivery Market in Canada: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025
    • TABLE 31: Canadian Injectable Drugs Delivery Market Quantitative Demand Analysis in $ Million by End-Use: 2018 to 2025
    • TABLE 32: Injectable Drugs Delivery Market in Canada: Summarization of Historic Demand Patterns in $ Million by End-Use for 2009-2017
    • TABLE 33: Canadian Injectable Drugs Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
  • JAPAN
    • TABLE 34: Japanese Market for Injectable Drugs Delivery: Annual Sales Estimates and Projections in $ Million by Segment for the period 2018-2025
    • TABLE 35: Injectable Drugs Delivery Market in Japan: Historic Sales Analysis in $ Million by Segment for the Period 2009-2017
    • TABLE 36: Japanese Injectable Drugs Delivery Market Share Analysis by Segment: 2009 VS 2019 VS 2025
    • TABLE 37: Japanese Demand Estimates and Forecasts for Injectable Drugs Delivery in $ Million by End-Use: 2018 to 2025
    • TABLE 38: Japanese Injectable Drugs Delivery Market in $ Million by End-Use: 2009-2017
    • TABLE 39: Injectable Drugs Delivery Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 40: Chinese Injectable Drugs Delivery Market Growth Prospects in $ Million by Segment for the Period 2018-2025
    • TABLE 41: Injectable Drugs Delivery Historic Market Analysis in China in $ Million by Segment: 2009-2017
    • TABLE 42: Chinese Injectable Drugs Delivery Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 43: Chinese Demand for Injectable Drugs Delivery in $ Million by End-Use: 2018 to 2025
    • TABLE 44: Injectable Drugs Delivery Market Review in China in $ Million by End-Use: 2009-2017
    • TABLE 45: Chinese Injectable Drugs Delivery Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
  • EUROPE
    • Market Facts & Figures
    • European Injectable Drugs Delivery Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Device (Segment) Market Share (in %) by Company in Europe: 2019 & 2025
    • Formulation (Segment) Market Share (in %) of Major Players in Europe: 2019 & 2025
    • TABLE 46: European Injectable Drugs Delivery Market Demand Scenario in $ Million by Region/Country: 2018-2025
    • TABLE 47: Injectable Drugs Delivery Market in Europe: A Historic Market Perspective in $ Million by Region/Country for the Period 2009-2017
    • TABLE 48: European Injectable Drugs Delivery Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 49: European Injectable Drugs Delivery Market Estimates and Forecasts in $ Million by Segment: 2018-2025
    • TABLE 50: Injectable Drugs Delivery Market in Europe in $ Million by Segment: A Historic Review for the Period 2009-2017
    • TABLE 51: European Injectable Drugs Delivery Market Share Breakdown by Segment: 2009 VS 2019 VS 2025
    • TABLE 52: European Injectable Drugs Delivery Addressable Market Opportunity in $ Million by End-Use: 2018-2025
    • TABLE 53: Injectable Drugs Delivery Market in Europe: Summarization of Historic Demand in $ Million by End-Use for the Period 2009-2017
    • TABLE 54: European Injectable Drugs Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 55: Injectable Drugs Delivery Market in France by Segment: Estimates and Projections in $ Million for the Period 2018-2025
    • TABLE 56: French Injectable Drugs Delivery Historic Market Scenario in $ Million by Segment: 2009-2017
    • TABLE 57: French Injectable Drugs Delivery Market Share Analysis by Segment: 2009 VS 2019 VS 2025
    • TABLE 58: Injectable Drugs Delivery Quantitative Demand Analysis in France in $ Million by End-Use: 2018-2025
    • TABLE 59: French Injectable Drugs Delivery Historic Market Review in $ Million by End-Use: 2009-2017
    • TABLE 60: French Injectable Drugs Delivery Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
  • GERMANY
    • TABLE 61: Injectable Drugs Delivery Market in Germany: Recent Past, Current and Future Analysis in $ Million by Segment for the Period 2018-2025
    • TABLE 62: German Injectable Drugs Delivery Historic Market Analysis in $ Million by Segment: 2009-2017
    • TABLE 63: German Injectable Drugs Delivery Market Share Breakdown by Segment: 2009 VS 2019 VS 2025
    • TABLE 64: Injectable Drugs Delivery Market in Germany: Annual Sales Estimates and Forecasts in $ Million by End-Use for the Period 2018-2025
    • TABLE 65: German Injectable Drugs Delivery Market in Retrospect in $ Million by End-Use: 2009-2017
    • TABLE 66: Injectable Drugs Delivery Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 67: Italian Injectable Drugs Delivery Market Growth Prospects in $ Million by Segment for the Period 2018-2025
    • TABLE 68: Injectable Drugs Delivery Historic Market Analysis in Italy in $ Million by Segment: 2009-2017
    • TABLE 69: Italian Injectable Drugs Delivery Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 70: Italian Demand for Injectable Drugs Delivery in $ Million by End-Use: 2018 to 2025
    • TABLE 71: Injectable Drugs Delivery Market Review in Italy in $ Million by End-Use: 2009-2017
    • TABLE 72: Italian Injectable Drugs Delivery Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
  • UNITED KINGDOM
    • TABLE 73: United Kingdom Market for Injectable Drugs Delivery: Annual Sales Estimates and Projections in $ Million by Segment for the period 2018-2025
    • TABLE 74: Injectable Drugs Delivery Market in the United Kingdom: Historic Sales Analysis in $ Million by Segment for the Period 2009-2017
    • TABLE 75: United Kingdom Injectable Drugs Delivery Market Share Analysis by Segment: 2009 VS 2019 VS 2025
    • TABLE 76: United Kingdom Demand Estimates and Forecasts for Injectable Drugs Delivery in $ Million by End-Use: 2018 to 2025
    • TABLE 77: United Kingdom Injectable Drugs Delivery Market in $ Million by End-Use: 2009-2017
    • TABLE 78: Injectable Drugs Delivery Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 79: Rest of Europe Injectable Drugs Delivery Market Estimates and Forecasts in $ Million by Segment: 2018-2025
    • TABLE 80: Injectable Drugs Delivery Market in Rest of Europe in $ Million by Segment: A Historic Review for the Period 2009-2017
    • TABLE 81: Rest of Europe Injectable Drugs Delivery Market Share Breakdown by Segment: 2009 VS 2019 VS 2025
    • TABLE 82: Rest of Europe Injectable Drugs Delivery Addressable Market Opportunity in $ Million by End-Use: 2018-2025
    • TABLE 83: Injectable Drugs Delivery Market in Rest of Europe: Summarization of Historic Demand in $ Million by End-Use for the Period 2009-2017
    • TABLE 84: Rest of Europe Injectable Drugs Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 85: Injectable Drugs Delivery Market in Asia-Pacific by Segment: Estimates and Projections in $ Million for the Period 2018-2025
    • TABLE 86: Asia-Pacific Injectable Drugs Delivery Historic Market Scenario in $ Million by Segment: 2009-2017
    • TABLE 87: Asia-Pacific Injectable Drugs Delivery Market Share Analysis by Segment: 2009 VS 2019 VS 2025
    • TABLE 88: Injectable Drugs Delivery Quantitative Demand Analysis in Asia-Pacific in $ Million by End-Use: 2018-2025
    • TABLE 89: Asia-Pacific Injectable Drugs Delivery Historic Market Review in $ Million by End-Use: 2009-2017
    • TABLE 90: Asia-Pacific Injectable Drugs Delivery Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
  • REST OF WORLD
    • TABLE 91: Rest of World Injectable Drugs Delivery Market Estimates and Forecasts in $ Million by Segment: 2018 to 2025
    • TABLE 92: Rest of World Injectable Drugs Delivery Historic Market Review by Segment in $ Million: 2009-2017
    • TABLE 93: Injectable Drugs Delivery Market in Rest of World: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025
    • TABLE 94: Rest of World Injectable Drugs Delivery Market Quantitative Demand Analysis in $ Million by End-Use: 2018 to 2025
    • TABLE 95: Injectable Drugs Delivery Market in Rest of World: Summarization of Historic Demand Patterns in $ Million by End-Use for 2009-2017
    • TABLE 96: Rest of World Injectable Drugs Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

IV. COMPETITION

  • BAXTER INTERNATIONAL
  • ELCAM MEDICAL
  • ELI LILLY AND COMPANY
  • GERRESHEIMER AG
  • INJEX PHARMA GMBH
  • NOVARTIS INTERNATIONAL AG
  • NOVO NORDISK A/S
  • SCHOTT AG
  • TERUMO CORPORATION
  • TEVA PHARMACEUTICALS USA
  • WEST PHARMACEUTICAL SERVICES

V. CURATED RESEARCH

Back to Top